Abstract
This paper focuses on psychiatric aspects of portal-systemic encephalopathy (PSE) due to chronic liver disease and/or portal-systemic shunting. Clinical syndromes of PSE are discussed from the point of view of biological psychiatry, but, psychological consequences of concomitant cognitive disorders are also addressed. Psychiatric symptoms of early PSE and sleep disorders in patients with chronic liver disease are of specific interest.
Similar content being viewed by others
REFERENCES
Adams, R.D. and Foley J.M. (1953). The neurological disorder associated with liver disease. Research Publ. A. Res. Nerv. Ment. Dis. 32:198–237.
American Psychiatric Association (APA) (1994). Diagnostic and statistical manual of mental disorders, ed. 4. American Psychiatric Association, Washington/DC, USA.
Basile, A.S. and Jones, E.A. (1997). Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatol. 25:1303–1305.
Bengtsson, F., Bergqvist, P.B. and Apelqvist, G. (1997). Brain tryptophan perturbation in hepatic encephalopathy: implications for effects by neuropsychoactive drugs in clinical practice. Adv. Exp. Med. Biol. 420:1–33.
Butterworth, R.F. (1996). The neurobiology of hepatic encephalopathy. Semin. Liver Dis. 16:235–244.
Butterworth, R.F. (1997). Hepatic Encephalopathy: Disorder of Multiple Neurotransmitter Systems. In (C. Record and H. Al-Mardini, eds), Advances in Hepatic Encephalopathy and Metabolism in Liver Disease. Ipswich Book Company, Newcastle upon Tyne, Great Britain, pp. 167–175.
Chadwick, J. and Mann, W. (1950). The Medical Works of Hippocrates: "The Sacred Disease". Blackwell Scientific Publisher, Oxford, Great Britain, p. 191.
Collis, I. and Lloyd, G. (1992). Psychiatric aspects of liver disease. Br. J. Psychia. 161:12–22.
Conn, H.O. (1977). Trailmaking and number-connection tests in the assessment of mental state in portal-systemic encephalopathy. Am. J. Dig. Dis. 22:541–550.
Conn, H.O. and Lieberthal, M.M. (1978a). Pathogenesis of portal-systemic encephalopathy. In The Hepatic Coma Syndromes and Lactulose. Williams & Wilkins, Baltimore/MD, pp. 46–84.
Conn, H.O. and Lieberthal, M.M. (1978b). The syndrome of portal-systemic encephalopathy. In The Hepatic Coma Syndromes and Lactulose. Williams & Wilkins, Baltimore/MD, pp. 1–46
Cordoba, J., Cabrera, J., Latif, L., Penev, P., Zee, P. and Blei, A.T. (1998). High prevalence of sleep disturbance in cirrhosis. Hepatol. 27:339–345.
Davidson, E.A. and Summerskill, W.H.J. (1956). Psychiatric aspects of liver disease. Postgraduate Med. J. 32:487–494.
Ewusi-Mensah, I., Saunders, J.B., Wodak, A.D., Murray, R.M. and Williams, R. (1983). Psychiatric morbidity in patients with alcoholic liver disease. Br. Med. J. 287:1417–1419.
Ferenci, P. (1997). Diagnosis and differential diagnosis of hepatic encephalopathy: Implications for the design of clinical studies. In (C. Record and H. Al-Mardini, eds) Advances in Hepatic Encephalopathy and Metabolism in Liver Disease. Ipswich Book Company, Newcastle upon Tyne, Great Britain, pp. 267–272.
Ferenci, P., Herneth, A. and Steindl, P. (1996). Newer approaches to therapy of hepatic encephalopathy. Semin. Liver Dis. 16:329–338.
Gilberstadt, S.J., Gilberstadt, H., Zieve, L., Buegel, B., Collier, R.O. and McClain, C.J. (1980). Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch. Intern. Med. 140:519–521.
Groeneweg, M., Quero, J.C., Essink-Bot, M.L., Hop, W.C.J. and Schalm, S.W. (1997). The effect of subclinical hepatic encephalopathy on the quality of life. In (C. Record and H. Al-Mardini, eds) Advances in Hepatic Encephalopathy and Metabolism in Liver Disease. Ipswich Book Company, Newcastle upon Tyne, Great Britain, pp. 311–317.
Inoue, E., Hori, S. and Narumi, Y. (1991). Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiol. 179:551–555.
Jabbour, N., Zajko, A.B., Orons, P.D., Irish, W., Bartoli, F., Marsh, W.J. et al. (1996). Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver. Transpl. Surg. 2:139–147.
Jalan, R., Gooday, R., Carroll, R.E., Redhead, D.N., Elton, R.A. and Hayes, P.C. (1995). A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. J. Hepatol. 23:697–705.
Jones, E.A. and Weissenborn, K. (1997). Neurology and the liver. J. Neurol. Neurosurg. Psychiatry 63:279–293.
Kornhuber, J., Wichart, I., Riederer, P., Kleinberger, G. and Jellinger, K. (1989). Kynurenine in hepatic encephalopathy. In (W. Stone, ed.), Quinolinic Acid and the Kynurenines. CRC Press, Boca Raton, USA, pp. 275–281.
Moore, J.W., Dunk, A.A., Crawford, J.R., Deans, H., Besson, J.A., De Lacey, G. et al. (1989). Neuropsychological deficits and MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis: a controlled study. J. Hepatol. 9:319–325.
Mullen, K.D. and Gacad, R. (1996). Hepatic encephalopathy. Gastroenterol. 4:188–202.
Nolte, W., Wiltfang, J., Schindler, C., Münke, H., Unterberg, K., Figulla, H.R. et al. (1998a). Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis: clinical, laboratory, psychometric and electroencephalographic investigations. Hepatol. (in press)
Nolte, W., Wiltfang, J., Schindler, C.G., Unterberg, K., Finkenstaedt, M., Niedmann, P.D. et al. (1998b). Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J. Hepatol. (in press)
Norenberg, M.D. (1996). Astrocytic-ammonia interactions in hepatic encephalopathy. Semin. Liver Dis. 16:245–253.
Ohnishi, K., Saito, M., Sato, S., Nakayama, T., Takashi, M., Sida, S. et al. (1985). Direction of splenic venous flow assessed by pulsed doppler flowmetry in patients with large splenorenal shunt. Relation to spontaneous hepatic encephalopathy. Gastroenterol. 89:180–185.
Paquet, K.J., Lazar A., Koussouris, P., Hotzel, B., Gad, H.A., Kuhn, R. and Kalk, J.F. (1995). Mesocaval interposition shunt with small-diameter polytetrafluoroethylene grafts in sclerotherapy failure. Br. J. Surg. 82:199–203.
Parsons-Smith, G., Summerskill, W.H.J., Dawson, A.M. and Sherlock, S. (1957). The electroencephalograph in liver disease. Lancet 2:867–871.
Planas, R., Gomes-Vieira, M.C., Cabre, E., Armengol, M., Quer, J.C., Boix, J., et al. (1992). Prognostic factors of hepatic encephalopathy after portacaval anastomosis: a multivariate analysis in 50 patients. Am. J. Gastroenterol. 87:1792–1796.
Pomier Layrargues, G. (1996). TIPS and hepatic encephalopathy. Semin. Liver Dis. 16:315–320.
Pomier Layrargues, G., Spahr, L. and Butterworth, R.F. (1995). Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345:735.
Quero, J.C., de Bruijn, I., Hartmann, I.J.C. and Schalm, S.W. (1995). Does subclinical hepatic encephalopathy affect quality of life? [Abstract]. Gastroenterol. 108:1151A.
Quero, J.C. and Schalm, S.W. (1996). Subclinical hepatic encephalopathy. Semin. Liver Dis. 16:321–328.
Rehnstrom, S., Simert, G., Hansson, J.A., Johnsson, G. and Vang, J. (1977). Chronic hepatic encephalopathy: a psychometrical study. Scand. J. Gastroent. 12:305–311.
Rikkers, L., Jenko, P., Rudman, D. and Freides, D. (1978). Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroent. 75:462–469.
Rössle, M., Deibert, P., Haag, K., Ochs, A., Olschewski, M., Siegerstetter, V. et al. (1997). Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 349:1043–1049.
Rössle, M., Siegerstetter, V., Huber, M. and Ochs, A. (1998). The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art [review article]. Liver 18:73–89.
Sanyal, A.J., Freedman, A.M., SHiffman, M.L., Purdum, P.P., Luketic, V.A. and Cheatham, A.K. (1994). Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatol. 20:46–55.
Sarfeh, I.J., Rypins, E.B., Conroy, R.M. and Mason, G.R. (1983). Portacaval H-graft: relationships of shunt diameter, portal flow patterns and encephalopathy. Ann. Surg. 197:422–426.
Sarin, S.K., Sachdev, G., Jildha, R.C., Siloah, R.C., Bhatt, A. and Munjal, G.C. (1988). Pattern of psychiatric morbidity and alcohol dependence in patients with alcoholic liver disease. Dig. Dis. Sci. 33:443–448.
Schomerus, H., Hamster, W., Blunck, H., Reinhard, O., Mayer K. and Dolle, W. (1981). Latent portal-systemic encephalopathy. I. Nature of cerebral functional defects and their effects on fitness to drive. Dig. Dis. Sci. 26:622–630.
Sherlock S. (1997). Hepatic Encephalopathy: Historical Review Up to 1975. In (C. Record and H. Al-Mardini, eds) Advances in Hepatic Encephalopathy and Metabolism in Liver Disease. Ipswich Book Company, Newcastle upon Tyne, Great Britain, pp. 159–163.
Sherlock, S., Summerskill, L.P. and Phear, E.A. (1954). Portal-systemic encephalopathy. Neurological complications of liver disease. Lancet 2:453–457.
Sherlock, S., Summerskill, W.H.J. and Dawson, A.M. (1956). The treatment and prognosis of hepatic coma. Lancet 2:689–694.
Simen, S., Hajak, G., Schlaf, G., Westenhofer, J., Rodenbeck, A., Bandelow, B. et al. (1995). Chronification of sleep disorders. Results from a representative survey in West Germany. Nervenarzt 66:686–695.
Somberg, K.A., Riegler, J.L., LaBerge, J.M., Doherty-Simor, M.M., Bachetti, P., Roberts, J.P. and Lake, J.R. (1995). Hepatic encephalopathy after transjugular intrahepatic protosystemic shunts: incidence and risk factors [see comments]. Am. J. Gastroenterol. 90:549–55.
Spitzer, R.L., First, M.B., Williams, J.B.W., Kendler, K., Pincus, H.A. and Tucker, G. (1992). Now is the time to retire the term "organic mental disorders". Am. J. Psychiatry 49:240.
Steindl, P.E., Finn, B., Bendok, B., Rothke, S., Zee, P.C. and Blei, A.T. (1995). Disruption of the diurnal rhythm of plasma melatonin in cirrhosis. Ann. Intern. Med. 123:274–277.
Summerskill, W.H.J., Davidson, E.A., Sherlock, S. and Steiner, R.E. (1956). The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation. Quart. J. Med. 25:245–266.
Surman, O.S. and Dienstag, J.L. (1987). Psychosomatic aspects of liver transplantation. Psychoth. Psychosomatics 48:26.
Tarter, R.E., Hegedus, A.M., Van Thiel, D.H., Schade, R.R., Gavaler, J S. and Starzl, T.E. (1984). Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterol. 86:1421–1427.
Tarter, R.E., van Thiel, D.H. and Arria, A.M. (1988). Impact of Cirrhosis on neuropsychological test performance of alcoholics. Alcoholism 12:619–621.
Trzepacz, P.T. and Dimartini, A. (1992). Survival of 247 liver transplant candidates. Relationship to pretransplant psychiatric variables and presence of delirium. General Hospital in Psychiatry 14:380.
van der Rijt, C.C. and Schalm, S.W. (1992). Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy. J. Hepatol. 14:141–2.
Victor, M., Adams, R.D. and Cole, M. (1965). The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine 44:345–396.
Weissenborn, K., Ruckert, N., Hecker, H. and Manns, M.P. (1998). The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy [In Process Citation]. J. Hepatol. 28:646–53.
Weissenborn, K., Scholz, M., Hinrichs, H., Wiltfang, J., Schmidt, F.W. and Kunkel, H. (1990). Neurophysiological assessment of early hepatic encephalopathy. Electroencephalogr. Clin. Neurophysiol. 75:289–295.
Weissman, M.M., Myers, J.K. and Harding, P.S. (1977). Prevalence and psychiatric heterogeneity of alcoholism in the United States urban community. J. Studies on Alcohol 41:672–681.
Wiltfang, J., Becker, H., Weißenborn, K., Thiel, A. and Manns, M. (1996). Prospective study on psychopathological syndromes in patients with non-alcohol-toxic liver cirrhosis awaiting liver transplantation [Abstract]. Europ. J. Gastroent. Hepat. 5(Suppl):15A
Wiltfang, J., Nolte, W., Figulla, H.R., Münke, H., Hartmann, H., von Heppe, J. et al. (1997). Organic Insomnia Following Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS). In (C. Record and Al-Mardini, eds) Advances in Hepatic Encephalopathy and Metabolism in Liver Disease. Ipswich Book Company, Newcastle upon Tyne, Great Britain, pp. 273–278.
Zeegen, R., Drinkwater, J.E. and Dawson, A.M. (1970). Method for measuring cerebral dysfunction in patients with liver disease. Br. Med. J. 2:633–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wiltfang, J., Nolte, W., Weißenborn, K. et al. Psychiatric Aspects of Portal-Systemic Encephalopathy. Metab Brain Dis 13, 379–389 (1998). https://doi.org/10.1023/A:1020697127718
Issue Date:
DOI: https://doi.org/10.1023/A:1020697127718